Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

AZD 5904 is an irreversible inhibitor of myeloperoxidase (MPO; IC50 = 0.2 µM in a cell-free assay).1 It enhances decreases in the mitochondrial membrane potential in, and the viability of, MOLM-14 acute myeloid leukemia (AML) cells when used in combination with cytarabine (Item No. 16069).2 AZD 5904 (75 µmol/kg) prevents high-fat diet-induced increases in microvascular blood flow and microvascular blood volume in rats.3
WARNING This product is not for human or veterinary use.
1. 2-
2. Targeting myeloperoxidase disrupts mitochondrial redox balance and overcomes cytarabine resistance in human acute myeloid leukemia. Cancer Res. 79(20), 5191-5203 (2019).
3. Inhibiting myeloperoxidase prevents onset and reverses established high-